These results indicate that full-length recombinant human ADPN with functional activity for the induction of AMPK and PPARα signaling pathways could be produced on a large-scale from egg white, and that the chicken bioreactor system could provide an economical source of recombinant human ADPN for the treatment of metabolic diseases. The gene discussed is PPARA; the disease is metabolic disease.